Medical Oncology

Cervical Cancer   

Questions discussed in this category



Do you include pembrolizumab with platinum-taxane + bevacizumab or reserve it as a second line option?

Do you try to keep Hb> 10 or 12? Or somewhere in between? 

Previously received pelvic EBRT and intracavitary brachytherapy. IORT was administered to the node-positive side wall at the time of exenteration.

Initially treated with definitive chemoRT but recurred with distant mets. Completed 6 cycles carb/tax/bev with minimal toxicity. Excellent performance...

Recurrence was 2cm and PET confirmed local. Excision with positive margins. Current plan for salvage whole pelvic RT and vaginal cuff brachytherapy +/...

This has been a common practice in the community. Is there a benefit for certain patients?

Would you be more or less likely to use a cisplatin-containing regimen if a patient had previously responded to chemoradiation with concurrent cisplat...

Should this be done at the time of recurrence or after failure of 1st line therapy for recurrence?


Papers discussed in this category


JAMA Netw Open, 2021 Apr 01

Clinical cancer research : an official journal of the American Association for Cancer Research, 2015-12-15

J. Clin. Oncol., 2011 Mar 28

BMC Cancer, 2017 Apr 28

N. Engl. J. Med.,

Lancet (London, England), 2017-10-07

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-06-10

J Clin Oncol, 2019 Nov 04

Lancet Oncol, 2021 Apr 09

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000-04

Gynecologic oncology, 1998-08

Gynecologic oncology, 2011-07

BMC Cancer, 2018 May 04

Gynecol Oncol, 2017 Sep 24

N Engl J Med, 2021 Sep 18

N Engl J Med, 2022 Jan 19